Antibody targeting the VP-1 protein, fragments thereof, and uses of same for detecting infection with the BK polyomavirus
US12365721B2 · kind B2 · utility
0Cited by
0References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 2, 2020 |
| Grant date | Jul 22, 2025 |
| Priority date | — |
| Expiry date | Nov 7, 2042 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a new monoclonal antibody targeting the VP-1 protein of the capsid of the BK polyomavirus, fragments thereof, and uses of same for detecting infection with the BK polyomavirus. The monoclonal antibody is capable of recognizing at least all serotypes Ia, Ib2, II, III and IV of the VP-1 protein of the BK polyomavirus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.